1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by Malignant Ascites Treatment Revenue 1.4 Market Analysis by Type 1.4.1 Global Malignant Ascites Treatment Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Paracentesis 1.4.3 Chemotherapy 1.4.4 Surgical Treatment 1.5 Market by Application 1.5.1 Global Malignant Ascites Treatment Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Coronavirus Disease 2019 (Covid-19): Malignant Ascites Treatment Industry Impact 1.6.1 How the Covid-19 is Affecting the Malignant Ascites Treatment Industry 1.6.1.1 Malignant Ascites Treatment Business Impact Assessment - Covid-19 1.6.1.2 Supply Chain Challenges 1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products 1.6.2 Market Trends and Malignant Ascites Treatment Potential Opportunities in the COVID-19 Landscape 1.6.3 Measures / Proposal against Covid-19 1.6.3.1 Government Measures to Combat Covid-19 Impact 1.6.3.2 Proposal for Malignant Ascites Treatment Players to Combat Covid-19 Impact 1.7 Study Objectives 1.8 Years Considered 2 Global Growth Trends by Regions 2.1 Malignant Ascites Treatment Market Perspective (2015-2026) 2.2 Malignant Ascites Treatment Growth Trends by Regions 2.2.1 Malignant Ascites Treatment Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Malignant Ascites Treatment Historic Market Share by Regions (2015-2020) 2.2.3 Malignant Ascites Treatment Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 Malignant Ascites Treatment Market Growth Strategy 2.3.6 Primary Interviews with Key Malignant Ascites Treatment Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top Malignant Ascites Treatment Players by Market Size 3.1.1 Global Top Malignant Ascites Treatment Players by Revenue (2015-2020) 3.1.2 Global Malignant Ascites Treatment Revenue Market Share by Players (2015-2020) 3.1.3 Global Malignant Ascites Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global Malignant Ascites Treatment Market Concentration Ratio 3.2.1 Global Malignant Ascites Treatment Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by Malignant Ascites Treatment Revenue in 2019 3.3 Malignant Ascites Treatment Key Players Head office and Area Served 3.4 Key Players Malignant Ascites Treatment Product Solution and Service 3.5 Date of Enter into Malignant Ascites Treatment Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type (2015-2026) 4.1 Global Malignant Ascites Treatment Historic Market Size by Type (2015-2020) 4.2 Global Malignant Ascites Treatment Forecasted Market Size by Type (2021-2026) 5 Malignant Ascites Treatment Breakdown Data by Application (2015-2026) 5.1 Global Malignant Ascites Treatment Market Size by Application (2015-2020) 5.2 Global Malignant Ascites Treatment Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Malignant Ascites Treatment Market Size (2015-2020) 6.2 Malignant Ascites Treatment Key Players in North America (2019-2020) 6.3 North America Malignant Ascites Treatment Market Size by Type (2015-2020) 6.4 North America Malignant Ascites Treatment Market Size by Application (2015-2020) 7 Europe 7.1 Europe Malignant Ascites Treatment Market Size (2015-2020) 7.2 Malignant Ascites Treatment Key Players in Europe (2019-2020) 7.3 Europe Malignant Ascites Treatment Market Size by Type (2015-2020) 7.4 Europe Malignant Ascites Treatment Market Size by Application (2015-2020) 8 Asia-Pacific 8.1 Asia-Pacific Malignant Ascites Treatment Market Size (2015-2020) 8.2 Malignant Ascites Treatment Key Players in Asia-Pacific (2019-2020) 8.3 Asia-Pacific Malignant Ascites Treatment Market Size by Type (2015-2020) 8.4 Asia-Pacific Malignant Ascites Treatment Market Size by Application (2015-2020) (2015-2020) (2015-2020) 9 Key Players Profiles 9.1 PharmaCyte Biotech 9.1.1 PharmaCyte Biotech Company Details 9.1.2 PharmaCyte Biotech Business Overview and Its Total Revenue 9.1.3 PharmaCyte Biotech Malignant Ascites Treatment Introduction 9.1.4 PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business (2015-2020)) 9.1.5 PharmaCyte Biotech Recent Development 9.2 Sequana Medical 9.2.1 Sequana Medical Company Details 9.2.2 Sequana Medical Business Overview and Its Total Revenue 9.2.3 Sequana Medical Malignant Ascites Treatment Introduction 9.2.4 Sequana Medical Revenue in Malignant Ascites Treatment Business (2015-2020) 9.2.5 Sequana Medical Recent Development 9.3 BioVie 9.3.1 BioVie Company Details 9.3.2 BioVie Business Overview and Its Total Revenue 9.3.3 BioVie Malignant Ascites Treatment Introduction 9.3.4 BioVie Revenue in Malignant Ascites Treatment Business (2015-2020) 9.3.5 BioVie Recent Development 9.4 BD 9.4.1 BD Company Details 9.4.2 BD Business Overview and Its Total Revenue 9.4.3 BD Malignant Ascites Treatment Introduction 9.4.4 BD Revenue in Malignant Ascites Treatment Business (2015-2020) 9.4.5 BD Recent Development 9.5 GI Supply 9.5.1 GI Supply Company Details 9.5.2 GI Supply Business Overview and Its Total Revenue 9.5.3 GI Supply Malignant Ascites Treatment Introduction 9.5.4 GI Supply Revenue in Malignant Ascites Treatment Business (2015-2020) 9.5.5 GI Supply Recent Development 9.6 Teva 9.6.1 Teva Company Details 9.6.2 Teva Business Overview and Its Total Revenue 9.6.3 Teva Malignant Ascites Treatment Introduction 9.6.4 Teva Revenue in Malignant Ascites Treatment Business (2015-2020) 9.6.5 Teva Recent Development 9.7 Mylan 9.7.1 Mylan Company Details 9.7.2 Mylan Business Overview and Its Total Revenue 9.7.3 Mylan Malignant Ascites Treatment Introduction 9.7.4 Mylan Revenue in Malignant Ascites Treatment Business (2015-2020) 9.7.5 Mylan Recent Development 9.8 GE 9.8.1 GE Company Details 9.8.2 GE Business Overview and Its Total Revenue 9.8.3 GE Malignant Ascites Treatment Introduction 9.8.4 GE Revenue in Malignant Ascites Treatment Business (2015-2020) 9.8.5 GE Recent Development 9.9 Trion 9.9.1 Trion Company Details 9.9.2 Trion Business Overview and Its Total Revenue 9.9.3 Trion Malignant Ascites Treatment Introduction 9.9.4 Trion Revenue in Malignant Ascites Treatment Business (2015-2020) 9.9.5 Trion Recent Development 10 Analyst's Viewpoints/Conclusions 11 Appendix 11.1 Research Methodology 11.1.1 Methodology/Research Approach 11.1.2 Data Source 11.2 Disclaimer 11.3 Author Details

List of Tables Table 1. Malignant Ascites Treatment Key Market Segments Table 2. Key Players Covered: Ranking by Malignant Ascites Treatment Revenue Table 3. Ranking of Global Top Malignant Ascites Treatment Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global Malignant Ascites Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Paracentesis Table 6. Key Players of Chemotherapy Table 7. Key Players of Surgical Treatment Table 8. COVID-19 Impact Global Market: (Four Malignant Ascites Treatment Market Size Forecast Scenarios) Table 9. Opportunities and Trends for Malignant Ascites Treatment Players in the COVID-19 Landscape Table 10. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis Table 11. Key Regions/Countries Measures against Covid-19 Impact Table 12. Proposal for Malignant Ascites Treatment Players to Combat Covid-19 Impact Table 13. Global Malignant Ascites Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 14. Global Malignant Ascites Treatment Market Size by Regions (US$ Million): 2020 VS 2026 Table 15. Global Malignant Ascites Treatment Market Size by Regions (2015-2020) (US$ Million) Table 16. Global Malignant Ascites Treatment Market Share by Regions (2015-2020) Table 17. Global Malignant Ascites Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 18. Global Malignant Ascites Treatment Market Share by Regions (2021-2026) Table 19. Market Top Trends Table 20. Key Drivers: Impact Analysis Table 21. Key Challenges Table 22. Malignant Ascites Treatment Market Growth Strategy Table 23. Main Points Interviewed from Key Malignant Ascites Treatment Players Table 24. Global Malignant Ascites Treatment Revenue by Players (2015-2020) (Million US$) Table 25. Global Malignant Ascites Treatment Market Share by Players (2015-2020) Table 26. Global Top Malignant Ascites Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malignant Ascites Treatment as of 2019) Table 27. Global Malignant Ascites Treatment by Players Market Concentration Ratio (CR5 and HHI) Table 28. Key Players Headquarters and Area Served Table 29. Key Players Malignant Ascites Treatment Product Solution and Service Table 30. Date of Enter into Malignant Ascites Treatment Market Table 31. Mergers & Acquisitions, Expansion Plans Table 32. Global Malignant Ascites Treatment Market Size by Type (2015-2020) (Million US$) Table 33. Global Malignant Ascites Treatment Market Size Share by Type (2015-2020) Table 34. Global Malignant Ascites Treatment Revenue Market Share by Type (2021-2026) Table 35. Global Malignant Ascites Treatment Market Size Share by Application (2015-2020) Table 36. Global Malignant Ascites Treatment Market Size by Application (2015-2020) (Million US$) Table 37. Global Malignant Ascites Treatment Market Size Share by Application (2021-2026) Table 38. North America Key Players Malignant Ascites Treatment Revenue (2019-2020) (Million US$) Table 39. North America Key Players Malignant Ascites Treatment Market Share (2019-2020) Table 40. North America Malignant Ascites Treatment Market Size by Type (2015-2020) (Million US$) Table 41. North America Malignant Ascites Treatment Market Share by Type (2015-2020) Table 42. North America Malignant Ascites Treatment Market Size by Application (2015-2020) (Million US$) Table 43. North America Malignant Ascites Treatment Market Share by Application (2015-2020) Table 44. Europe Key Players Malignant Ascites Treatment Revenue (2019-2020) (Million US$) Table 45. Europe Key Players Malignant Ascites Treatment Market Share (2019-2020) Table 46. Europe Malignant Ascites Treatment Market Size by Type (2015-2020) (Million US$) Table 47. Europe Malignant Ascites Treatment Market Share by Type (2015-2020) Table 48. Europe Malignant Ascites Treatment Market Size by Application (2015-2020) (Million US$) Table 49. Europe Malignant Ascites Treatment Market Share by Application (2015-2020) Table 50. Asia-Pacific Key Players Malignant Ascites Treatment Revenue (2019-2020) (Million US$) Table 51. Asia-Pacific Key Players Malignant Ascites Treatment Market Share (2019-2020) Table 52. Asia-Pacific Malignant Ascites Treatment Market Size by Type (2015-2020) (Million US$) Table 53. Asia-Pacific Malignant Ascites Treatment Market Share by Type (2015-2020) Table 54. Asia-Pacific Malignant Ascites Treatment Market Size by Application (2015-2020) (Million US$) Table 55. Asia-Pacific Malignant Ascites Treatment Market Share by Application (2015-2020) Table 56. PharmaCyte Biotech Company Details Table 57. PharmaCyte Biotech Business Overview Table 58. PharmaCyte Biotech Product Table 59. PharmaCyte Biotech Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 60. PharmaCyte Biotech Recent Development Table 61. Sequana Medical Company Details Table 62. Sequana Medical Business Overview Table 63. Sequana Medical Product Table 64. Sequana Medical Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 65. Sequana Medical Recent Development Table 66. BioVie Company Details Table 67. BioVie Business Overview Table 68. BioVie Product Table 69. BioVie Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 70. BioVie Recent Development Table 71. BD Company Details Table 72. BD Business Overview Table 73. BD Product Table 74. BD Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 75. BD Recent Development Table 76. GI Supply Company Details Table 77. GI Supply Business Overview Table 78. GI Supply Product Table 79. GI Supply Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 80. GI Supply Recent Development Table 81. Teva Company Details Table 82. Teva Business Overview Table 83. Teva Product Table 84. Teva Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 85. Teva Recent Development Table 86. Mylan Company Details Table 87. Mylan Business Overview Table 88. Mylan Product Table 89. Mylan Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 90. Mylan Recent Development Table 91. GE Business Overview Table 92. GE Product Table 93. GE Company Details Table 94. GE Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 95. GE Recent Development Table 96. Trion Company Details Table 97. Trion Business Overview Table 98. Trion Product Table 99. Trion Revenue in Malignant Ascites Treatment Business (2015-2020) (Million US$) Table 100. Trion Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Malignant Ascites Treatment Market Share by Type: 2020 VS 2026 Figure 2. Paracentesis Features Figure 3. Chemotherapy Features Figure 4. Surgical Treatment Features Figure 5. Global Malignant Ascites Treatment Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Others Case Studies Figure 9. Malignant Ascites Treatment Report Years Considered Figure 10. Global Malignant Ascites Treatment Market Size YoY Growth 2015-2026 (US$ Million) Figure 11. Global Malignant Ascites Treatment Market Share by Regions: 2020 VS 2026 Figure 12. Global Malignant Ascites Treatment Market Share by Regions (2021-2026) Figure 13. Porter's Five Forces Analysis Figure 14. Global Malignant Ascites Treatment Market Share by Players in 2019 Figure 15. Global Top Malignant Ascites Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Malignant Ascites Treatment as of 2019 Figure 16. The Top 10 and 5 Players Market Share by Malignant Ascites Treatment Revenue in 2019 Figure 17. North America Malignant Ascites Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 18. Europe Malignant Ascites Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 19. Asia-Pacific Malignant Ascites Treatment Market Size YoY Growth (2015-2020) (Million US$) Figure 20. PharmaCyte Biotech Total Revenue (US$ Million): 2019 Compared with 2018 Figure 21. PharmaCyte Biotech Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 22. Sequana Medical Total Revenue (US$ Million): 2019 Compared with 2018 Figure 23. Sequana Medical Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 24. BioVie Total Revenue (US$ Million): 2019 Compared with 2018 Figure 25. BioVie Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 26. BD Total Revenue (US$ Million): 2019 Compared with 2018 Figure 27. BD Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 28. GI Supply Total Revenue (US$ Million): 2019 Compared with 2018 Figure 29. GI Supply Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 30. Teva Total Revenue (US$ Million): 2019 Compared with 2018 Figure 31. Teva Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 32. Mylan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 33. Mylan Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 34. GE Total Revenue (US$ Million): 2019 Compared with 2018 Figure 35. GE Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 36. Trion Total Revenue (US$ Million): 2019 Compared with 2018 Figure 37. Trion Revenue Growth Rate in Malignant Ascites Treatment Business (2015-2020) Figure 38. Bottom-up and Top-down Approaches for This Report Figure 39. Data Triangulation Figure 40. Key Executives Interviewed

PharmaCyte Biotech Sequana Medical BioVie BD GI Supply Teva Mylan GE Trion